Pharmafile Logo

Peter Impey

Pegasus strengthens its Pharma and Life Sciences division

Appoints three new team members to join its Northern base

Can we ‘outsmart’ smartphone addiction by using it to develop effective health apps?

Are you guilty of repeatedly checking your phone 24/7? Our new blog explores what makes them so addictive and how understanding this may help us develop more effective health apps.

Say Communications

- PMLiVE

Lucid welcome their graduate Customer Experience Managers

Lucid has had an incredibly busy summer attending recruitment fairs all across the country to find the finest graduate talent for their Futures Executive Programme. As part of its graduate...

Lucid Group Communications Limited

- PMLiVE

Janssen launches UK blood cancer awareness campaign

The pharma group join forces with designer to set up ‘giant’ names in London

- PMLiVE

Dismay as NICE turns down first-line use of AZ’s Faslodex

Says evidence isn’t convincing for use in post-menopausal women

- PMLiVE

Indivior slumps as patent dispute rises US generic spectre

The RB spin out will appeal against the ruling

- PMLiVE

Amgen signs real world study and mobile data partnership

Will work with health and wellbeing group Humana on risk prevention

- PMLiVE

Up close and personal

How the need for engagement and differentiation is helping pharma break down social barriers

- PMLiVE

Therachon appoints Christian Meyer as chief medical officer

He succeeds Maarten Kraan who remains as an advisor

- PMLiVE

The science of experience planning in pharma media

Our digital lead, Richard Springham, looks at how the principles of behavioural science and experience planning are used in best practice pharma media planning.

Four Agency Worldwide

- PMLiVE

Who will be the new disrupter of HCP media

Our digital lead, Richard Springham, looks at the move of the tech behemoths and the impact on HCP media.

Four Agency Worldwide

Why I think rare disease companies are more patient-centric

Guest blogger Kamlesh Sheth believes companies that specialise in rare disease tend to be more patient-centric.

Say Communications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links